Skip to content
Review

N-Acetyltransferase 10 (NAT10) at the crossroads of metabolism, immunology, and cancer biology

Aug 2026 · Cancer Metastasis Review · Vol 45 · 0 citations · 94 references
Medicine

TL;DR

A conceptual framework of how the dysfunction of the highly conserved NAT10 leads to tumorigenesis, metastasis, and therapeutic resistance is provided and the major findings that reveal how NAT10 regulates cancer metabolism and immune responses are summarized.

View source

Similar papers

Review Sep 2026

RNF5: an emerging therapeutic target for modulating immunity and metabolism.

A comprehensive overview of the multifaceted functions of RNF5 is provided, with particular emphasis on its context-dependent roles in cancer progression, antiviral immunity, and non-neoplastic diseases.

Ruo-Bing He, Jiao Wang, Meng-Jia Lin et al. · 0 citations
Review Open access Aug 2026

The m6A Reader YTHDC2: Molecular Mechanisms and Regulatory Networks in Disease Pathogenesis

This review systematically synthesizes current knowledge regarding the multifaceted roles of YTHDC2 in disease progression, prognosis, and therapy, offering a comprehensive framework to guide future investigations.

Yan-Ying Hu, Qi Zhou, Ning Xu et al. · 0 citations
Open access Aug 2026

Virus-induced deconjugation of ISG15 dysregulates innate immunity and cellular metabolism.

Interferon-stimulated gene 15 (ISG15) encodes a ubiquitin-like protein that regulates diverse cellular responses, including antiviral immunity, through its conjugation to proteins in a process known as ISGylation. Several pathogens, including SARS-CoV-2, subvert ISGylation by encoding deISGylating enzymes. However, the...

Jun-Ji Zhu, Guan-Qun Liu, Jie-Lin Xu et al. · 0 citations
Review Open access Sep 2026

The role and clinical impact of aberrant m6A RNA modification in cancer

This review systematically dissects how dysregulated m6A methylation fuels malignant transformation and progression by reinforcing core oncogenic hallmarks, sustained proliferation, metastasis, metabolic rewiring, and resistance to programmed cell death.

Sheng-Jie Tang, Rangping Xie, Jiang Fu et al. · 0 citations
Review Aug 2026

RNA modifications as determinants of cancer cell death: from epitranscriptomic mechanisms to therapeutic targeting

It is argued that while epitranscriptomics represents a compelling regulatory axis in cancer cell death, advancing the field will require integrative, high-resolution, and functionally precise approaches to move beyond correlative frameworks toward mechanistic and clinically actionable insights.

A. Mukherjee, Ankit Kumar Bharti, D. Mathew et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.